14-56580017-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_017799.4(TMEM260):c.103G>A(p.Ala35Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000101 in 1,248,520 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017799.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TMEM260 | NM_017799.4 | c.103G>A | p.Ala35Thr | missense_variant | 1/16 | ENST00000261556.11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TMEM260 | ENST00000261556.11 | c.103G>A | p.Ala35Thr | missense_variant | 1/16 | 2 | NM_017799.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152248Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000200 AC: 4AN: 19984Hom.: 0 AF XY: 0.000310 AC XY: 3AN XY: 9676
GnomAD4 exome AF: 0.000100 AC: 110AN: 1096272Hom.: 0 Cov.: 30 AF XY: 0.0000811 AC XY: 42AN XY: 518052
GnomAD4 genome AF: 0.000105 AC: 16AN: 152248Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74382
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.103G>A (p.A35T) alteration is located in exon 1 (coding exon 1) of the TMEM260 gene. This alteration results from a G to A substitution at nucleotide position 103, causing the alanine (A) at amino acid position 35 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at